About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Single Dose Antibiotic as Effective in Treating Skin Diseases as Twice-Daily Infusion

by Kathy Jones on June 5, 2014 at 8:37 PM
Font : A-A+

 Single Dose Antibiotic as Effective in Treating Skin Diseases as Twice-Daily Infusion

Researchers at Duke Medicine have found that a new single-dose antibiotic was as effective in treating stubborn skin infections, including methicillin-resistant Staphylococcus aureus (MRSA), as a twice-daily infusion given for up to 10 days.

Researchers said the advantage of the new drug, oritavancin, is its potential to curtail what has been a key driver of antibiotic resistance: a tendency for patients to stop taking antibiotics once they feel better. In such instances, the surviving bacteria may become impervious to the drugs designed to fight them.

Advertisement

"The prolonged activity is what makes oritavancin distinctive," said G. Ralph Corey, M.D., lead author of the study published June 5, 2014, in the New England Journal of Medicine (NEJM). "This drug has a long half-life, which allows for a single-dose treatment."

Corey, a professor of medicine and infectious diseases at Duke University School of Medicine, led a three-year study of oritavancin that encompassed two large clinical trials enrolling nearly 2,000 patients. Findings from the trials will be presented to the U.S. Food and Drug Administration as part of the drug's approval application.
Advertisement

Results reported in the NEJM are for the first of the two clinical trials, which included 475 patients randomized to take the investigational drug, and 479 patients following a typical regimen of vancomycin, including two infusions a day, for seven to 10 days.

Researchers found that the single intravenous dose of oritavancin was as effective as vancomycin in shrinking the size of the lesion and reducing fever. Both were also similar in rates of requiring a rescue antibiotic.

The new antibiotic also performed similarly to vancomycin in reducing the area of the wound by 20 percent or more within the first 48-72 hours of treatment, and in curing the patients of infection, including those infected with MRSA.

"Having a single-dose drug could potentially prevent hospitalizations or reduce the amount of time patients would spend in the hospital," Corey said.
Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Diet and Oral Health: The Sugary Connection May Become Sour
World AIDS Day 2022 - Equalize!
Test Your Knowledge on Sugar Intake and Oral Health
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Boils / Skin Abscess Skin Disease Pityriasis rosea Pemphigus Hives Scleroderma MRSA - The Super Bug Drug Resistance - Antibiotic Resistance Vitiligo Skin Self Examination 

Most Popular on Medindia

Drug Side Effects Calculator Drug - Food Interactions Calculate Ideal Weight for Infants Blood - Sugar Chart Vent Forte (Theophylline) Blood Pressure Calculator Sinopril (2mg) (Lacidipine) Find a Hospital How to Reduce School Bag Weight - Simple Tips Turmeric Powder - Health Benefits, Uses & Side Effects
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Single Dose Antibiotic as Effective in Treating Skin Diseases as Twice-Daily Infusion Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests